Browsing publications by Dr Barry Davies

Newcastle AuthorsTitleYear
Dr Simon Bomken
Dr Barry Davies
Mike Cole
Dr Katrina Wood
Maritsa McDermott
et al.
Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival2011
Simon Dovedi
Professor John Kirby
Dr Barry Davies
Professor Hing Leung
John Kelly
et al.
Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma2008
Dr Simon Bomken
Dr Barry Davies
Dr Katrina Wood
Professor Deborah Tweddle
Tumour necrosis following chemotherapy in neuroblastoma correlates with MYC-N status but not survival2007
Professor Richard Edmondson
John Monaghan
Dr Barry Davies
Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium2006
Islay Steele
Professor Richard Edmondson
Professor Hing Leung
Dr Barry Davies
Ligands to FGF receptor 2-IIIb induce proliferation, motility, protection from cell death and cytoskeletal rearrangements in epithelial ovarian cancer cell lines2006
Pallavi Mehrotra
Dr Sarah Johnson
Professor Janet Wilson
Dr Barry Davies
Professor Thomas Lennard
et al.
Mcm-2 and Ki-67 have limited potential in preoperative diagnosis of thyroid malignancy2006
Simon Dovedi
Professor John Kirby
Dr Helen Maitland
Dr Barry Davies
John Kelly
et al.
Cyclooxygenase-2 inhibition: A potential mechanism for increasing the efficacy of bacillus Calmette-Guerin immunotherapy for bladder cancer2005
Dr Johnny Roughan
Professor Paul Flecknell
Dr Barry Davies
Behavioural assessment of the effects of tumour growth in rats and the influence of tne analgesics carprofen and meloxicam2004
Dr Gordon Strathdee
Dr Barry Davies
Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene2004
Jose Dominguez-Escrig
John Kelly
Professor David Neal
Dr Sonya King
Dr Barry Davies
et al.
Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer2004
123